Table 1 (abstract A81). Characteristics of patients affected by Intensive Care Unit Acquired Weakness (ICUAW)
From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
Parameters | Pt 1 | Pt 2 | Pt 3 | Pt 4 | Pt 5 | Pt 6 |
|---|---|---|---|---|---|---|
Age (y) | 64 | 56 | 58 | 38 | 17 | 46 |
Gender (M/F) | M | M | F | F | M | M |
Body Mass Index | 26,6 | 22,2 | 34,2 | 33,5 | 20,5 | 25 |
Hyperglycemia | Yes | Yes | Yes | Yes | Yes | Yes |
MELD score | 30 | 38 | 40 | 40 | 40 | 31 |
D-MELD | 810 | 912 | 3105 | 3160 | 1062 | 2139 |
SAPS II score | 46 | 76 | 49 | 60 | 67 | 67 |
Etiology: | ||||||
 Alchool | No | Yes | No | Yes | No | No |
 Virus | No | Yes | No | No | No | No |
 Hepatocarcinoma | No | Yes | No | No | No | No |
 Other | Cryptogenetic | - | Polycystosis | - | Cryptogenetic | Trauma |
ICU stay before LT (d) | 0 | 4 | 5 | 9 | 6 | 13 |
PNF | No | Yes | Yes | No | No | No |
Lenght of surgery (h) | 11,5 | 6 | 9 | 14 | 11 | 9 |
Duration of MV (h) | 168 | 75 | 144 | 336 | 150 | 180 |
Tracheostomy | Yes | No | No | No | No | Yes |
RBC U IO | 36 | 18 | 19 | 11 | 10 | 6 |
FFP U IO | 23 | 14 | 8 | 5 | 10 | 5 |
PLT U IO | 9 | 5 | 3 | 2 | 2 | 0 |
Norepinephrine | Yes | Yes | Yes | Yes | Yes | Yes |
Mycophenolate | Yes | Yes | Yes | Yes | Yes | Yes |
Tacrolimus | Yes | Yes | Yes | Yes | Yes | Yes |
Corticosteroids | Yes | Yes | Yes | Yes | Yes | Yes |
Serum CPK (U/L) | 74 | 113 | 239 | < 15 | 2000 | 80 |
Rejection | No | No | No | No | No | No |
Infection site | Blood | Blood+BAL | Blood | Urine | Blood+BAL | Blood+Ascites |
ICUAW (days post LT) | 14 | 8 | 8 | 8 | 3 | 13 |
ICUAW recovery | Yes | Yes | Yes | Yes | Yes | Yes |
Pre-LT CVVH | No | Yes | No | Yes | Yes | Yes |
Post-LT CVVH | Yes | Yes | Yes | Yes | Yes | Yes |
LOS in ICU (d) | 79 | 14 | 20 | 20 | 16 | 53 |
LOS in hospital (d) | 187 | 53 | 68 | 85 | 83 | 177 |
90 days outcome | Alive | Alive | Alive | Alive | Alive | Alive |